Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Kleo Announces CD38-ARM as First Clinical Candidate in Partnership with PeptiDream

americanpharmaceuticalreviewJune 20, 2019

Tag: Kleo Pharmaceuticals , endogenous antibodies , Kleo

PharmaSources Customer Service